These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7439262)

  • 1. Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K
    Eur J Clin Pharmacol; 1980 Nov; 18(5):403-6. PubMed ID: 7439262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion.
    Caillier I; Bannwarth B; Monot C; Lapicque F; Netter P; Gaucher A; Royer RJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):7-13. PubMed ID: 2303312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K; Zlnay D
    Eur J Clin Pharmacol; 1984; 26(4):457-61. PubMed ID: 6734706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibuprofen kinetics in plasma and synovial fluid of arthritic patients.
    Gallo JM; Gall EP; Gillespie WR; Albert KS; Perrier D
    J Clin Pharmacol; 1986 Jan; 26(1):65-70. PubMed ID: 3950052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The distribution of benorylate in plasma, synovial fluid and synovial tissue in rheumatoid arthritis].
    Manz G; Glynn JP
    Z Rheumatol; 1975; 34(11-12):400-7. PubMed ID: 1915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous pharmacokinetics of benorylate in plasma and synovial fluid of patients with rheumatoid arthritis.
    Aylward M; Maddock J; Rees P; Thomas GM; Wheeldon R; Holly F
    Scand J Rheumatol Suppl; 1975; 13():9-12. PubMed ID: 8841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients.
    Wanwimolruk S; Brooks PM; Birkett DJ
    Br J Clin Pharmacol; 1983 Jan; 15(1):91-4. PubMed ID: 6849750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro protein binding of diclofenac sodium in plasma and synovial fluid.
    Chan KK; Vyas KH; Brandt KD
    J Pharm Sci; 1987 Feb; 76(2):105-8. PubMed ID: 3572745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of the salicylates.
    Needs CJ; Brooks PM
    Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and synovial fluid gentisate in patients receiving salicylate therapy.
    Cleland LG; Lowthian PJ; Imhoff D; Bochner F; Betts WH; O'Callaghan J
    J Rheumatol; 1985 Feb; 12(1):136-9. PubMed ID: 3981499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIMULTANEOUS SALICYLATE CONCENTRATIONS IN SYNOVIAL FLUID AND PLASMA IN RHEUMATOID ARTHRITIS.
    ROSENTHAL RK; BAYLES TB; FREMONT-SMITH K
    Arthritis Rheum; 1964 Apr; 7():103-9. PubMed ID: 14150739
    [No Abstract]   [Full Text] [Related]  

  • 13. Protein binding of salicylate in uremic and normal plasma.
    Borgå O; Cederlöf IO; Ringberger VA; Norlin A
    Clin Pharmacol Ther; 1976 Oct; 20(4):464-75. PubMed ID: 975718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of benorylate in plasma, synovial fluid and tissue in rheumatoid arthritis.
    Franke M; Manz G; Glynn JP
    Scand J Rheumatol Suppl; 1975; 13():13-7. PubMed ID: 8833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.
    Aarons L; Salisbury R; Alam-Siddiqi M; Taylor L; Grennan DM
    Br J Clin Pharmacol; 1986 Feb; 21(2):155-63. PubMed ID: 3954931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio.
    Hinderling PH; Hartmann D; Crevoisier C; Moser U; Heizmann P
    Ther Drug Monit; 1988; 10(3):250-60. PubMed ID: 3262939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The passage of benorylate into the synovial fluid and tissue of rheumatoid patients.
    Laine VA; Penn RG; Pätiälä H; Sibelius R
    Scand J Rheumatol Suppl; 1975; 13():18-20. PubMed ID: 8834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time for salicylate diffusion from blood to joint fluid. A study of histopathology of the synovial membrane.
    Soren A
    Reumatismo; 1977; 29(1):1-6. PubMed ID: 618099
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha 2-macroglobulin-proteinase complexes as correlated with alpha 1-proteinase inhibitor-elastase complexes in synovial fluids of rheumatoid arthritis patients.
    Borth W; Dunky A; Kleesiek K
    Arthritis Rheum; 1986 Mar; 29(3):319-25. PubMed ID: 2421737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transsynovial distribution and protein binding of pirazolac in patients with rheumatoid arthritis.
    Kurowski M; Dunky A; Geddawi M
    Eur J Clin Pharmacol; 1986; 31(3):307-11. PubMed ID: 3792428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.